RGEN - REPLIGEN CORP
125.84
2.780 2.209%
Share volume: 666,470
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$123.06
2.78
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-01-2024 | 07-30-2024 | 11-18-2024 | 03-13-2025 | 04-29-2025 | 08-07-2025 | 11-04-2025 | 02-26-2026 | |
| Total revenue | 151.346 M | 154.073 M | 154.871 M | 167.547 M | 169.172 M | 182.366 M | 188.805 M | 197.913 M | |
| Cost of revenue | 76.391 M | 77.314 M | 77.383 M | 128.706 M | 78.415 M | 91.224 M | 88.290 M | 94.082 M | |
| Gross profit | 74.955 M | 76.759 M | 77.488 M | 38.841 M | 90.757 M | 91.142 M | 100.515 M | 103.831 M | |
| 2.41% | 0.95% | -49.87% | 133.66% | 0.42% | 10.28% | 3.30% | |||
| Operating expenses | 72.924 M | 75.272 M | 85.320 M | 72.151 M | 84.179 M | 85.185 M | 87.838 M | 87.483 M | |
| Selling general and admin | 61.686 M | 64.697 M | 75.610 M | 60.474 M | 71.255 M | 71.227 M | 73.663 M | 74.363 M | |
| Research and development | 11.238 M | 10.575 M | 9.710 M | 11.677 M | 12.924 M | 13.958 M | 14.175 M | 13.120 M | |
| Total expenses | 149.315 M | 152.586 M | 85.320 M | 75.342 M | 84.179 M | 77.246 M | 83.690 M | 85.963 M | |
| 2.19% | -44.08% | -11.69% | 11.73% | -8.24% | 8.34% | 2.72% | |||
| Operating income | 2.031 M | 1.487 M | -7.832 M | -36.501 M | 6.578 M | 13.896 M | 16.825 M | 17.868 M | |
| Ebit | 2.031 M | 1.487 M | -5.157 M | -41.439 M | 5.879 M | 16.984 M | 15.605 M | 17.854 M | |
| Pretax income | 2.114 M | 5.182 M | -1.149 M | -38.608 M | 7.943 M | 18.215 M | 17.112 M | 19.113 M | |
| 145.13% | -122.17% | 3,260.14% | -120.57% | 129.32% | -6.06% | 11.69% | |||
| Income tax | 20.000 K | 1.861 M | -495.000 K | -4.739 M | 2.113 M | 3.349 M | 2.201 M | 5.826 M | |
| Net income basic | 2.094 M | 3.321 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 58.60% | -100.00% | ||||||||
| Net income | 2.094 M | 3.321 M | -654.000 K | -33.869 M | 5.830 M | 14.866 M | 14.911 M | 13.287 M | |
| 58.60% | -119.69% | -5,078.75% | 117.21% | 154.99% | 0.30% | -10.89% |